Correlation Between Invivyd and Entera Bio
Can any of the company-specific risk be diversified away by investing in both Invivyd and Entera Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Invivyd and Entera Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Invivyd and Entera Bio, you can compare the effects of market volatilities on Invivyd and Entera Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Invivyd with a short position of Entera Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Invivyd and Entera Bio.
Diversification Opportunities for Invivyd and Entera Bio
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Invivyd and Entera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Invivyd and Entera Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entera Bio and Invivyd is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Invivyd are associated (or correlated) with Entera Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entera Bio has no effect on the direction of Invivyd i.e., Invivyd and Entera Bio go up and down completely randomly.
Pair Corralation between Invivyd and Entera Bio
Given the investment horizon of 90 days Invivyd is expected to generate 5.84 times more return on investment than Entera Bio. However, Invivyd is 5.84 times more volatile than Entera Bio. It trades about 0.1 of its potential returns per unit of risk. Entera Bio is currently generating about -0.05 per unit of risk. If you would invest 46.00 in Invivyd on December 29, 2024 and sell it today you would earn a total of 15.00 from holding Invivyd or generate 32.61% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Invivyd vs. Entera Bio
Performance |
Timeline |
Invivyd |
Entera Bio |
Invivyd and Entera Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Invivyd and Entera Bio
The main advantage of trading using opposite Invivyd and Entera Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Invivyd position performs unexpectedly, Entera Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will offset losses from the drop in Entera Bio's long position.Invivyd vs. Recursion Pharmaceuticals | Invivyd vs. Atea Pharmaceuticals | Invivyd vs. Unity Biotechnology | Invivyd vs. Regenxbio |
Entera Bio vs. NLS Pharmaceutics AG | Entera Bio vs. Alterity Therapeutics | Entera Bio vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Global Correlations Find global opportunities by holding instruments from different markets |